Carlsmed, Inc.
CARL
$16.28
$0.070.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.20% | 18.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.20% | 18.59% | |||
| Cost of Revenue | -2.08% | 25.89% | |||
| Gross Profit | 11.93% | 16.15% | |||
| SG&A Expenses | 29.49% | 9.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.96% | 16.83% | |||
| Operating Income | -38.96% | -13.69% | |||
| Income Before Tax | -26.01% | -18.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -26.01% | -18.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.01% | -18.10% | |||
| EBIT | -38.96% | -13.69% | |||
| EBITDA | -39.00% | -13.42% | |||
| EPS Basic | 72.57% | -0.40% | |||
| Normalized Basic EPS | 72.56% | -10.64% | |||
| EPS Diluted | 72.57% | -0.40% | |||
| Normalized Diluted EPS | 72.56% | -10.64% | |||
| Average Basic Shares Outstanding | 359.32% | 6.75% | |||
| Average Diluted Shares Outstanding | 359.32% | 6.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||